Pay in 4 interest-free payments of $6.31 Learn more
Ships within 48 hours · Estimated delivery Aug 31 - Sep 5
North Am
(2017) 93:882896.e5
Abstract Introduction: To evaluate the efficacy of a novel eye drop formulation containing hyaluronic acid (0.2%) and butyroyl-glutathione (GSHC4, 0.4%) in glaucoma-associated ocular surface disease (G-OSD), and to explore putative mechanisms of action through in vitro assays of corneal epithelial wound healing and cytokine modulation under basal, inflammatory, and oxidative stress conditions
More below
Le glutathion seul nest jamais spectaculaire , mais intgr dans une routine cohrente, il peut faire la diffrence
US$ 26.52
US$ 20.58
US$ 29.89
US$ 20.36
